162 related articles for article (PubMed ID: 35491849)
1. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.
Li M; Jiang H; Chen S; Ma Y
Bioengineered; 2022 Apr; 13(4):11320-11341. PubMed ID: 35491849
[TBL] [Abstract][Full Text] [Related]
2. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma.
Chen F; Yang L; Peng X; Mao M; Liu X; Song J; Hu J
Mol Immunol; 2022 Nov; 151():204-217. PubMed ID: 36179603
[TBL] [Abstract][Full Text] [Related]
4. p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway.
Liu C; Zhang Y; Li J; Wang Y; Ren F; Zhou Y; Wu Y; Feng Y; Zhou Y; Su F; Jia B; Wang D; Chang Z
J Biol Chem; 2015 Apr; 290(15):9701-13. PubMed ID: 25697359
[TBL] [Abstract][Full Text] [Related]
5. HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer.
Lin CL; Tsai ML; Lin CY; Hsu KW; Hsieh WS; Chi WM; Huang LC; Lee CH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669676
[TBL] [Abstract][Full Text] [Related]
6. NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer.
Li Z; Liu B; Li C; Sun S; Zhang H; Sun S; Wang Z; Zhang X
Front Oncol; 2021; 11():634026. PubMed ID: 33816275
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase HDAC2 regulates microRNA-125a expression in neuroblastoma.
Liu D; Tang X; Huang Z; Wen J; Zhou Y
Brain Behav; 2022 Feb; 12(2):e2401. PubMed ID: 35060363
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).
Liu YR; Wang JQ; Huang ZG; Chen RN; Cao X; Zhu DC; Yu HX; Wang XR; Zhou HY; Xia Q; Li J
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013366
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract][Full Text] [Related]
10. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase HDAC2 silencing prevents endometriosis by activating the HNF4A/ARID1A axis.
Mai H; Liao Y; Luo S; Wei K; Yang F; Shi H
J Cell Mol Med; 2021 Nov; 25(21):9972-9982. PubMed ID: 34586697
[TBL] [Abstract][Full Text] [Related]
12. Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo.
Salmon M; Gomez D; Greene E; Shankman L; Owens GK
Circ Res; 2012 Aug; 111(6):685-96. PubMed ID: 22811558
[TBL] [Abstract][Full Text] [Related]
13. 1,25(OH)
Huang J; Yang G; Huang Y; Zhang S
Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
[TBL] [Abstract][Full Text] [Related]
14. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
16. NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.
Zhang L; Ge C; Zhao F; Zhang Y; Wang X; Yao M; Li J
Cancer Res; 2016 Dec; 76(23):7059-7071. PubMed ID: 27634758
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
[TBL] [Abstract][Full Text] [Related]
18. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.
Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ
Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389
[TBL] [Abstract][Full Text] [Related]
19. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
[TBL] [Abstract][Full Text] [Related]
20. GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells.
Seo MJ; Liu X; Chang M; Park JH
Int J Oncol; 2012 Mar; 40(3):655-64. PubMed ID: 22020876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
